Condition
Early Lung Cancer
Total Trials
5
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Recruiting2
Not Yet Recruiting2
Unknown1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07405931Not ApplicableRecruiting
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
NCT07064876Phase 2Not Yet RecruitingPrimary
Serplulimab Combined With Cryoablation for Early-Stage Non-Small Cell Lung Cancer
NCT01993498Not ApplicableRecruiting
Chronic Toxicities Related to Treatment in Patients With Localized Cancer
NCT05802654Not ApplicableNot Yet RecruitingPrimary
Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer
NCT03542253UnknownPrimary
Combined Diagnosis of CT and Exosome in Early Lung Cancer
Showing all 5 trials